Abstract
The purpose of this study was to compare the in vitro reactivation of the various molecular forms of soman-inhibited acetylcholinesterase by oximes such as HI-6, toxogonin and PAM, in striated muscle tissue from three species-rat, monkey and human. To simulate the various in vivo conditions the oxime was present either 5 min before and after (Pre-Post) or 5 min after (Post) exposure to the nerve agent soman. In the Pre-Post mode the oxime effects would result from a combination of not only shielding of acetylcholinesterase from soman inhibition but also from immediate reactivation of soman-inhibited acetylcholinesterase. In the Post experimental group the increase in soman-inhibited acetylcholinesterase activity was due to reactivation. HI-6 (Pre-Post) increased significantly the activity of soman-inhibited acetylcholinesterase in the rat, human and monkey muscle. HI-6 (Post) was a highly effective reactivator of soman-inhibited acetylcholinesterase in the rat muscle and moderately so in the human and monkey muscle. Toxogonin (Pre-Post) and toxogonin (Post) were effective in increasing soman-inhibited acetylcholinesterase activity in rat muscle but were relatively ineffective in the human and monkey muscle. PAM (Pre-Post) and PAM (Post) were ineffective in increasing soman-inhibited acetylcholinesterase activity in muscle from all species examined. Effectiveness of oxime-induced reactivation of soman-inhibited acetylcholinesterase could be estimated from the total acetylcholinesterase activity which appears to reflect the results found with the individual molecular forms of acetylcholinesterase. In addition, SAD-128, a non-oxime bispyridinium compound, appeared to enhance significantly the HI-6 induced reactivation of soman-inhibited acetylcholinesterase in human but not rat striated muscle.
Similar content being viewed by others
References
Berends F (1987) Mechanisms of ageing of organophosphate-inhibited esterases. In: De Matteis F, Lock EA (eds) Structure molecular mechanisms toxicity, McMillan Press, UK, pp 125–152
Boskovic B (1981) The treatment of soman poisoning and its perspectives. Fundam Appl Toxicol 1: 203–213
Clement JG (1979) Efficacy of PRO-PAM (Af-methyl-l,6-dihydropyridine-2-carbaldoxime hydrochloride) as a prophylaxis against organophosphate poisoning. Toxicol Appl Pharmacol 47: 305–311
Clement JG (1981) Toxicology and pharmacology of bispyridinium oximes — insight into the mechanism of action vs soman poisoning in vivo. Fundam Appl Toxicol 1: s193-s202
Clement JG (1983) Efficacy of mono- and bis-pyridinium oximes versus soman, sarin and tabun poisoning in mice. Fundam Appl Toxicol 3: 533–535
Clement JG (1991) Variability of sarin-induced hypothermia in mice: investigation into incidence and mechanism. Biochem Pharmacol 42: 1316–1318
Clement JG, Lee MJ, Simons KJ, Briggs CJ (1990) Pharmacokinetics of the acetylcholinesterase oxime reactivator, HI-6, in rhesus monkeys (Macaca mulatto): effect of atropine, diazepam and methoxyflurane anesthesia. Biopharm Drug Dispos 11: 227–232
Clement JG, Pierce CH, Houle J-M (1992) Ascending dose tolerance study of the oxime, HI-6, in man. Proc 4th International Symposium, Protection Against Chemical Warfare Agents, June 8-12, 1992 Stockholm, Sweden
Clement JG, Madill HD, Bailey DG, Spence JD (1993) Clinical study of a new therapy for nerve agent poisoning: ascending dose tolerance study of HI-6 + atropine in man. United States Army 1993 Medical Defense Bioscience Review. May 10-13,1993 Baltimore, Md.
Clement JG, Rosario S, Bessette E, Erhardt N (1991) Soman and sarin inhibition of molecular forms of acetylcholinesterase in mice: time course of recovery and reactivation by the oxime HI-6. Biochem Pharmacol 42: 329–335
DeJong LPA, Wolring GZ (1980) Reactivation of acetylcholinesterase inhibited by l,2,2'-trimethylpropyl methylphosphonofluoridate (soman) with HI-6 and related oximes. Biochem Pharmacol 29: 2379–2387
DeJong LPA, Wolring GZ (1984) Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species including man, inhibited by soman. Biochem Pharmacol 33: 1119–1125
Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88–95
Ferguson G (1971) Statistical analysis in psychology and education, McGraw-Hill, New York
Grubic Z, Tomazic A (1989) Mechanism of action of HI-6 on soman inhibition of acetylcholinesterase in preparations of rat and human skeletal muscle; comparison to SAD-128 and PAM-2. Arch Toxicol 63: 68–71
Hamilton MG, Lundy PM (1989) HI-6 therapy of soman and tabun poisoning in primates and rodents. Arch Toxicol 63: 144–149
Harris LW, Heyl WC, Stitcher DL, Broomfield CA (1978) Effects of 1,1-oxydimethylene bis-(4-tert-butylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman and sarin-inhibited Cholinesterase by oximes. Biochem Pharmacol 27: 757–761
Heffron PF, Hobbiger F (1979) Relationship between inhibition of acetylcholinesterase and response of the rat phrenic nerve-diaphragm preparation to indirect stimulation at higher frequencies. Br J Pharmacol 66: 323–329
Inestrosa NC, Perelman A (1989) Distribution and anchoring of molecular forms of acetylcholinesterase. Trends Pharmacol Sei 10: 325–329
Koelle GB, Gilman A (1946) The chronic toxicity of di-isopropyl fluorophosphate (DFP) in dogs, monkeys and rats. J Pharmacol Exp Ther 87: 435–448
Kusic R, Boskovic B, Vqjvodic V, Jovanovic D (1985) HI-6 in man: blood levels, urinary excretion and tolerance after intramuscular administration of the oxime to healthy volunteers. Fundam Appl Toxicol 5: S89-S97
Lipp J, Dola T (1980) Comparison of the efficacy of HS-6 versus HI-6 when combined atropine, pyridostigmine and clonazepam for soman poisoning in the monkey. Arch Int Pharmacodyn Ther 246: 138–148
Lomax P, Kokka N, Lee R (1986) Acetylcholinesterase inhibitors and thermoregulation. In: Cooper K, Lomax P, Schonbaum G (eds) Homeostasis thermal stress. 6th International Symposium, Karger, Basel, pp 108–112
Massoulie J, Bon S (1982) The molecular forms of Cholinesterase and acetylcholinesterase in vertebrates. Annu Rev Neurobiol 5: 57–106
Meeter E, Wolthuis OL (1968) The spontaneous recovery of respiration and neuromuscular transmission in the rat after anticholinesterase poisoning. Eur J Pharmacol 2: 377–386
Puu G, Artursson E, Bucht G (1986) Reactivation of nerve agent inhibited human acetylcholinesterases by HI-6 and obidoxime. Biochem Pharmacol 35: 1505–1510
Schoene K (1978) Aging of soman-inhibited acetylcholinesterase: inhibitors and accelerators. Biochim Biophys Acta 525: 468–471
Shih TM (1993) Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue Cholinesterase activity in rats. Arch Toxicol 67: 637–646
Stale A, Sentjurc M (1990) A contribution to the mechanism of action of SAD-128. Biochem Pharmacol 40: 2511–2517
Tattersall JEH (1993) Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro. Br J Pharmacol 108: 1006–1015
Van Helden HPM, Van der Weil HJ, DeLange J, Busker RW, MelchersBPC, Wolthuis OL (1992) Therapeutic efficacy of HI-6 in soman poisoned marmoset monkeys. Toxicol Appl Pharmacol 115: 50–56
Wolthuis OL, Kepner LA (1978) Successful oxime therapy one hour after soman intoxication in the rat. Eur J Pharmacol 49: 415–425
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clement, J.G., Erhardt, N. In vitro oxime-induced reactivation of various molecular forms of soman-inhibited acetylcholinesterase in striated muscle from rat, monkey and human. Arch Toxicol 68, 648–655 (1994). https://doi.org/10.1007/BF03208345
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03208345